Melatonin has been found to inhibit iNOS expression in murine macrophages through inhibiting NF-κB activation, but its role in diabetes-accelerated atherosclerosis and the underlying mechanism is largely unknown. This evidence concerns the gene NFKB1 and atherosclerosis.